Login / Signup

Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma.

Anchal GhaiAlexander ZheleznyakMatt MixdorfJulie O'NealJulie RitcheyMichael RettigJohn DiPersioMonica ShokeenSamuel Achilefu
Published in: European journal of nuclear medicine and molecular imaging (2020)
These data demonstrate the feasibility of [89Zr]DFO-elotuzumab as a companion diagnostic for CS1-targeted therapies.
Keyphrases
  • multiple myeloma
  • pet imaging
  • high resolution
  • electronic health record
  • big data
  • mass spectrometry
  • data analysis
  • photodynamic therapy